Advertisement
SIGA vs XERS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SIGA is a Hold and XERS is a Hold.
SIGA in downward trend: price dove below 50-day moving average on October 13, 2026
SIGA moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend. In 23 of 27 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 85%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SIGA as a result. In 73 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.
The Moving Average Convergence Divergence Histogram (MACD) for SIGA turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 32 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SIGA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 10-day moving average for SIGA crossed bullishly above the 50-day moving average on September 25, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
Following a +3.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where SIGA advanced for three days, in 232 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
SIGA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 138 of 178 cases where SIGA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.504) is normal, around the industry mean (43.873). P/E Ratio (11.214) is within average values for comparable stocks, (141.710). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (2.152). SIGA's Dividend Yield (0.081) is considerably higher than the industry average of (0.005). P/S Ratio (4.161) is also within normal values, averaging (178.797).
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. SIGA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIGA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
XERS's RSI Oscillator peaks and leaves overbought zone
The 10-day RSI Indicator for XERS moved out of overbought territory on October 13, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 instances where the indicator moved out of the overbought zone. In 38 of the 44 cases the stock moved lower in the days that followed. This puts the odds of a move down at 86%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 55 of 65 cases where XERS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XERS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
XERS broke above its upper Bollinger Band on September 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for XERS entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 21, 2026. You may want to consider a long position or call options on XERS as a result. In 76 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.
The Moving Average Convergence Divergence (MACD) for XERS just turned positive on September 21, 2026. Looking at past instances where XERS's MACD turned positive, the stock continued to rise in 35 of 43 cases over the following month. The odds of a continued upward trend are 81%.
XERS moved above its 50-day moving average on September 21, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for XERS crossed bullishly above the 50-day moving average on September 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 77%.
Following a +3.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where XERS advanced for three days, in 219 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 27 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. XERS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (107.527) is normal, around the industry mean (43.873). P/E Ratio (115.929) is within average values for comparable stocks, (141.710). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (4.196) is also within normal values, averaging (178.797).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
SIGA | XERS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 92 | 44 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 1 Undervalued | 85 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 27 | |
SMR RATING 1..100 | 91 | 100 | |
PRICE GROWTH RATING 1..100 | 63 | 35 | |
P/E GROWTH RATING 1..100 | 9 | 22 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SIGA's Valuation (1) in the Pharmaceuticals Other industry is significantly better than the same rating for XERS (85) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew significantly faster than XERS’s over the last 12 months.
XERS's Profit vs Risk Rating (27) in the Pharmaceuticals Major industry is significantly better than the same rating for SIGA (100) in the Pharmaceuticals Other industry. This means that XERS’s stock grew significantly faster than SIGA’s over the last 12 months.
SIGA's SMR Rating (91) in the Pharmaceuticals Other industry is in the same range as XERS (100) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew similarly to XERS’s over the last 12 months.
XERS's Price Growth Rating (35) in the Pharmaceuticals Major industry is in the same range as SIGA (63) in the Pharmaceuticals Other industry. This means that XERS’s stock grew similarly to SIGA’s over the last 12 months.
SIGA's P/E Growth Rating (9) in the Pharmaceuticals Other industry is in the same range as XERS (22) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew similarly to XERS’s over the last 12 months.
| SIGA | XERS | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 86% |
| Stochastic ODDS (%) | 1 day ago 76% | 1 day ago 85% |
| Momentum ODDS (%) | 1 day ago 83% | 1 day ago 89% |
| MACD ODDS (%) | 1 day ago 67% | 1 day ago 81% |
| TrendWeek ODDS (%) | 1 day ago 79% | 1 day ago 84% |
| TrendMonth ODDS (%) | 1 day ago 80% | 1 day ago 86% |
| Advances ODDS (%) | 10 days ago 79% | 6 days ago 86% |
| Declines ODDS (%) | 1 day ago 75% | 1 day ago 77% |
| BollingerBands ODDS (%) | 1 day ago 67% | 1 day ago 82% |
| Aroon ODDS (%) | 1 day ago 78% | 1 day ago 78% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
SIGA’s FA Score shows that 2 FA rating(s) are green while XERS’s FA Score has 2 green FA rating(s).
- SIGA’s FA Score: 2 green, 3 red.
- XERS’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
SIGA’s TA Score shows that 5 TA indicator(s) are bullish while XERS’s TA Score has 5 bullish TA indicator(s).
- SIGA’s TA Score: 5 bullish, 4 bearish.
- XERS’s TA Score: 5 bullish, 5 bearish.
Price Growth
SIGA (@Pharmaceuticals: Generic) experienced а -6.38% price change this week, while XERS (@Pharmaceuticals: Generic) price change was +1.29% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.86%. For the same industry, the average monthly price growth was -3.86%, and the average quarterly price growth was +15.65%.
Reported Earning Dates
SIGA is expected to report earnings on Nov 05, 2026.
XERS is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-3.86% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
SIGA and
Correlation & Price change
A.I.dvisor tells us that SIGA and EBS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGA and EBS's prices will move in lockstep.
| Ticker / NAME | Correlation To SIGA | 1D Price Change % | ||
|---|---|---|---|---|
| SIGA | 100% | -2.53% | ||
| EBS - SIGA | 33% Poorly correlated | -1.00% | ||
| ETON - SIGA | 30% Poorly correlated | -3.48% | ||
| AYTU - SIGA | 27% Poorly correlated | +1.02% | ||
| AMRX - SIGA | 27% Poorly correlated | -2.30% | ||
| XERS - SIGA | 25% Poorly correlated | -2.49% | ||
More | ||||
XERS and
Correlation & Price change
A.I.dvisor indicates that over the last year, XERS has been loosely correlated with MIRM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if XERS jumps, then MIRM could also see price increases.
| Ticker / NAME | Correlation To XERS | 1D Price Change % | ||
|---|---|---|---|---|
| XERS | 100% | -2.49% | ||
| MIRM - XERS | 45% Loosely correlated | -7.48% | ||
| KROS - XERS | 38% Loosely correlated | -3.27% | ||
| AXON - XERS | 37% Loosely correlated | -0.26% | ||
| REPL - XERS | 36% Loosely correlated | -7.35% | ||
| BNTC - XERS | 36% Loosely correlated | -4.85% | ||
More | ||||